Achieve Life Sciences, Inc. (ACHV) Financials

ACHV Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 24.3 million 20.3 million
2023-06-30 28.9 million 19.2 million
2023-03-31 20.8 million 20.4 million
2022-12-31 30.0 million 21.7 million

ACHV Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -5.2 million 1.2 million
2023-06-30 -6.7 million 1.2 million
2023-03-31 -8.3 million 1.1 million
2022-12-31 -11.1 million 778000

ACHV Net Income

No data available :(

ACHV Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 19.9 million - 83000
2023-06-30 25.1 million - 98000
2023-03-31 16.5 million - 112000
2022-12-31 24.8 million - 127000

ACHV Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 21.1 million
2023-06-30 19.0 million
2023-03-31 17.9 million
2022-12-31 13.5 million

ACHV Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 15000 3.6 million 3.0 million -
2023-06-30 - 4.6 million 3.1 million -
2023-03-31 - 5.5 million 3.0 million -
2022-12-31 - 8.6 million 2.2 million -

ACHV Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 100000
2023-06-30 - 100000
2023-03-31 - 58000
2022-12-31 - 65000

ACHV

Price: $4.61

52 week price:
3.03
10.30

Earnings Per Share: -1.50 USD

P/E Ratio: -2.15

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 92500

Ebitda: -8.6 million

Market Capitalization: 149.3 million

Links: